US News & World Report recently announced that Thornton Law Firm has been recognized as one of the Best Law Firms for the year 2014. US News started ranking firms through Best Lawyers in 2010. Thornton Law Firm has been a nationally ranked Tier 1 Best Law Firm in Mass Torts & Class Actions since the first edition.
Although only approved by the Food and Drug Administration for certain patients with specific psychiatric disorders, Johnson & Johnson marketed Risperdal for a variety of non-approved, “off label,” uses. This marketing resulted in widespread use of Risperdal by individuals with other mental health issues.
Today there are multiple news reports of great interest to people suffering from defective hip replacements: Johnson & Johnson’s subsidiary DePuy Orthopaedics has agreed to a tentative settlement of over 4 billion dollars to resolve thousands of DePuy Articular Surface Replacement (ASR) hip implant lawsuits. This would make it the largest recorded settlement for a defective medical device in US history.
Posted by Thornton Law Firm LLP on Nov 11, 2013 3:17:00 PM Tammy Duckworth is a congresswoman from Illinois’s 8th Congressional District. As a Black Hawk helicopter pilot, she was one of the first women to fly combat missions in Iraq until November 12th, 2004...
Yesterday, voters in several Colorado and Ohio cities and towns voted on a series of fracking bans and restrictions. Voters in Colorado municipalities Boulder, Broomfield, Fort Collins, and Lafayette decided whether to pass restrictions on “fracking” in those communities. Residents in Boulder and Fort Collins approved five-year fracking moratoriums. At last count, the Broomfield vote was nearly tied, and only 13 votes separated the two sides. Lafayette’s measure, one that bans fracking completely, also passed.
Johnson & Johnson’s Janssen Pharmaceutical unit has been ordered to pay $4.02 million in a lawsuit claiming its anti-seizure drug Topamax was responsible for a child’s birth defect, a Philadephia jury said last week.
Posted by Thornton Law Firm LLP on Oct 25, 2013 4:30:00 AM Long before smartphone applications were sold with the catchphrase “There’s an app for that,” the notion of a cure-all for any situation has always been the province of chemicals. More than ever, we are...
A second DePuy ASR hip implant case scheduled for trial this month has been resolved, according to court records. The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.
The lawsuit, MacDonald et al v. DePuy Orthopaedics Inc. et al, was filed in the Bergen County division of the New Jersey Superior Court and was scheduled to go to trial on October 21, 2013 before the Honorable Brian R. Martinotti. There are few details about the settlement available at this time and, as with prior Depuy hip settlements, the terms will likely remain confidential.
Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit before trial. The case would have been the first “bellwether” trial in a California state court consolidation of ASR cases. The Plaintiff, Mr. Robert Eugene Ottman, was set to begin presenting his case in two weeks in state court in San Francisco.
By Patricia M. Flannery, Esq. Posted on Oct 2, 2013 Overshadowed by the continuing debate over the government shutdown is the apparent fate of legislative protection of companies responsible for genetically modified organisms (“GMO”). In March of this year,...
By Michael A. Lesser, Esq. Posted on Oct 2, 2013 The Securities and Exchange Commission (“SEC”) just announced an award of more than $14 million to a single whistleblower whose information led to an SEC enforcement action that recovered substantial investor...
By Michael A. Lesser, Esq. Posted on Sep 25, 2013 Dr. Frances Oldham Kelsey Released in Germany in 1957 as an all-purpose sedative, but later widely used as a preventative treatment for “morning sickness,”...
